Does DEFERASIROX Cause Hyperammonaemia? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Hyperammonaemia have been filed in association with DEFERASIROX (Deferasirox). This represents 0.6% of all adverse event reports for DEFERASIROX.
65
Reports of Hyperammonaemia with DEFERASIROX
0.6%
of all DEFERASIROX reports
5
Deaths
41
Hospitalizations
How Dangerous Is Hyperammonaemia From DEFERASIROX?
Of the 65 reports, 5 (7.7%) resulted in death, 41 (63.1%) required hospitalization, and 31 (47.7%) were considered life-threatening.
Is Hyperammonaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Hyperammonaemia?
VALPROIC ACID (581)
VALPROATE (328)
FLUOROURACIL (263)
DIVALPROEX (256)
LEVETIRACETAM (192)
TACROLIMUS (181)
ACETAMINOPHEN (177)
OXALIPLATIN (160)
TOPIRAMATE (156)
GLYCEROL PHENYLBUTYRATE (147)
Which DEFERASIROX Alternatives Have Lower Hyperammonaemia Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX